Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-02

Clinical Trial Update: Insulin Glulisine in Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on insulin glulisine in type 2 diabetes. Results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin glulisine (Apidra) (insulin glulisine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2009-12-02